OGG1 and Alzheimer disease: Shao et al. [10] demonstrated that mitochondrial OGG1 activity decreased in the frontal and temporal lobe of late-stage AD and in the temporal lobe of the mild cognitive impairment (MCI) patients, compromising the removal of oxidatively damaged bases from mtDNA.